Elicio Therapeutics, Inc. ELTX
1.68 USD -0.07 -4.00%
At close
1.80 +0.12 +7.14%
Pre-market · Nov 2, 7:31 AM ET
- YTD
- -78.89%
- 1 year
- -81.84%
- Open
- 1.74
- Prev close
- 1.75
- Mkt cap
- 45.51M
- Vol
- 183.88K
- Avg vol
- 309.85K
- EPS
- -2.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.66
- High
- 1.78
- Forward P/E
- -1.96
- Beta
- 0.00
- Short ratio
- 2.49
- Inst. own
- 5.82%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 4.92
- 200-d avg
- 5.97
- 1y target
- 9.50
MAX chart
Chart tools
Chart is warming up
The all-time price history for ELTX has not been loaded yet. Try again in a moment.
Altman Z-Score
-14.25 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -3.1×
P/S 0.0×
P/B 74.5×
P/FCF -3.3×
EV/EBITDA -3.2×
EV/Sales 0.0×
FCF Yield -30.3%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -2418.8%
ROIC -201.0%
ROA -153.0%
Revenue 0.0%
Operating Income 16.2%
EPS (diluted) 39.3%
Free Cash Flow 0.5%
Current Ratio 2.4×
Quick Ratio 2.4×
Debt / Equity 8.9×
Net Debt / EBITDA 0.1×
Interest Coverage -33.3×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31